Zoledronic acid 1mg
Products billed under this code include Reclast, Zoledronic Acid.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Reclast, Zoledronic Acid.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Reclast | Sandoz Inc. | 66758-0155-46 | 5 | $88.365 |
| Zoledronic Acid | Northstar RxLLC | 16714-0815-01 | 4 | $70.692 |
| Zoledronic Acid | Accord Healthcare Inc | 16729-0242-31 | 4 | $70.692 |
| Zoledronic Acid | Heritage Pharmaceuticals Inc. | 23155-0170-31 | 4 | $70.692 |
| Zoledronic Acid | Sagent Pharmaceuticals | 25021-0801-66 | 4 | $70.692 |
| Zoledronic Acid | Sagent Pharmaceuticals | 25021-0826-67 | 4 | $70.692 |
| Zoledronic Acid | Sagent Pharmaceuticals | 25021-0826-82 | 4 | $70.692 |
| Zoledronic Acid | Sagent Pharmaceuticals | 25021-0830-82 | 5 | $88.365 |
| Zoledronic Acid | Sagent Pharmaceuticals | 25021-0830-87 | 25 | $441.825 |
| Zoledronic Acid | Dr. Reddy's Laboratories Inc. | 43598-0233-11 | 4 | $70.692 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Zoledronic Acid | Dr. Reddy's Laboratories Inc. | 55111-0685-07 | 4 | $70.692 |
| Zoledronic Acid | Dr. Reddy's Laboratories Inc. | 55111-0688-52 | 5 | $88.365 |
| Zoledronic Acid | FreseniUS Kabi USA, LLC | 63323-0961-98 | 4 | $70.692 |
| Zoledronic Acid | FreseniUS Kabi USA, LLC | 63323-0966-00 | 5 | $88.365 |
| Zoledronic Acid | Mylan Institutional LLC | 67457-0390-54 | 4 | $70.692 |
| Zoledronic Acid | Mylan Institutional LLC | 67457-0619-10 | 5 | $88.365 |
| Zoledronic Acid | Mylan Institutional LLC | 67457-0794-10 | 5 | $88.365 |
| Zoledronic Acid | BluePoint Laboratories | 68001-0437-25 | 4 | $70.692 |
| Zoledronic Acid | BluePoint Laboratories | 68001-0610-25 | 4 | $70.692 |
| Zoledronic Acid | BluePoint Laboratories | 68001-0611-33 | 5 | $88.365 |
| Zoledronic Acid | Athenex Pharmaceutical Division, LLC | 70860-0210-51 | 4 | $70.692 |
| Zoledronic Acid | Athenex Pharmaceutical Division, LLC | 70860-0802-82 | 5 | $88.365 |
| Zoledronic Acid | Meitheal Pharmaceuticals Inc. | 71288-0806-51 | 5 | $88.365 |
| Zoledronic Acid | Fosun Pharma USA Inc. | 72266-0152-01 | 5 | $88.365 |
| Zoledronic Acid | Northstar RxLLC | 72603-0198-01 | 4 | $70.692 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $17.673 | +$14.312 | 1 MG | Zoledronic acid 1mg | v1, posted September 17, 2026 |
| 3Q26 | $3.361 | −$27.517 | 1 MG | Zoledronic acid 1mg | v1, posted September 15, 2026 |
| 2Q26 | $30.878 | +$25.796 | 1 MG | Zoledronic acid 1mg | v1, posted September 15, 2026 |
| 1Q26 | $5.082 | +$0.026 | 1 MG | Zoledronic acid 1mg | v1, posted September 15, 2026 |
| 4Q25 | $5.056 | −$0.147 | 1 MG | Zoledronic acid 1mg | v1, posted September 8, 2026 |
| 3Q25 | $5.203 | −$4.32 | 1 MG | Zoledronic acid 1mg | v1, posted March 10, 2026 |
| 2Q25 | $9.523 | +$3.919 | 1 MG | Zoledronic acid 1mg | v1, posted March 10, 2026 |
| 1Q25 | $5.604 | −$0.868 | 1 MG | Zoledronic acid 1mg | v1, posted December 19, 2025 |
| 4Q24 | $6.472 | +$0.746 | 1 MG | Zoledronic acid 1mg | v1, posted June 11, 2025 |
| 3Q24 | $5.726 | −$1.209 | 1 MG | Zoledronic acid 1mg | v1, posted June 11, 2025 |
| 2Q24 | $6.935 | −$0.278 | 1 MG | Zoledronic acid 1mg | v1, posted March 11, 2025 |
| 1Q24 | $7.213 | +$0.279 | 1 MG | Zoledronic acid 1mg | v1, posted December 19, 2024 |
| 4Q23 | $6.934 | −$2.151 | 1 MG | Zoledronic acid 1mg | v1, posted October 10, 2024 |
| 3Q23 | $9.085 | +$0.987 | 1 MG | Zoledronic acid 1mg | v1, posted June 5, 2024 |
| 2Q23 | $8.098 | −$3.043 | 1 MG | Zoledronic acid 1mg | v1, posted February 23, 2024 |
| 1Q23 | $11.141 | +$2.773 | 1 MG | Zoledronic acid 1mg | v1, posted December 6, 2023 |
| 4Q22 | $8.368 | +$0.025 | 1 MG | Zoledronic acid 1mg | v1, posted June 22, 2023 |
| 3Q22 | $8.343 | +$1.699 | 1 MG | Zoledronic acid 1mg | v1, posted June 9, 2023 |
| 2Q22 | $6.644 | +$0.877 | 1 MG | Zoledronic acid 1mg | v1, posted December 14, 2022 |
| 1Q22 | $5.767 | −$2.48 | 1 MG | Zoledronic acid 1mg | v1, posted June 8, 2022 |
| 4Q21 | $8.247 | −$3.895 | 1 MG | Zoledronic acid 1mg | v1, posted June 2, 2022 |
| 3Q21 | $12.142 | +$1.207 | 1 MG | Zoledronic acid 1mg | v1, posted June 2, 2022 |
| 2Q21 | $10.935 | +$0.635 | 1 MG | Zoledronic acid 1mg | v1, posted March 1, 2022 |
| 1Q21 | $10.30 | – | 1 MG | Zoledronic acid 1mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.